NCT01226602View on ClinicalTrials.gov

Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects.

PHASE1CompletedINTERVENTIONAL

Enrollment

39

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Blood Flow SpeedCoronary Flow Velocity

Interventions

DRUG

AZD6140

P2Y12 receptor antagonist

DRUG

Placebo

Trial Locations (1)

Unknown

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT01226602 - Study to Assess the Effect of Ticagrelor on Coronary Blood Flow in Healthy Male Subjects. | Biotech Hunter | Biotech Hunter